ResearcherUniversity of LiègeActive in the last 2 years
Sandy Anania
Matched on OpenAlex author ID A5050765712. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Co-author DOI 10.1186/s12964-024-01514-z↗
- Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.redox.2022.102324↗
- Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity through the Control of Oxidative Phosphoryla… Co-author DOI 10.3390/cancers11060853↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Akeila Bellahcène · 3 shared papers, 2019–2024 · strength 0.44
- Paper Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cel… DOI 10.1186/s12964-024-01514-z↗
- Paper Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2022.102324↗
- Paper Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity thro… DOI 10.3390/cancers11060853↗
- Olivier Peulen · 3 shared papers, 2019–2024 · strength 0.44
- Paper Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cel… DOI 10.1186/s12964-024-01514-z↗
- Paper Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2022.102324↗
- Paper Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity thro… DOI 10.3390/cancers11060853↗
- Raphaël Peiffer · 2 shared papers, 2022–2024 · strength 0.35
- Gilles Rademaker · 2 shared papers, 2019–2022 · strength 0.22
- Vincent Castronovo · 1 shared paper, 2022 · strength 0.13
- Brunella Costanza · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.